Global Oligonucleotides Market Research Report 2021
Global Oligonucleotides Market Research Report 2021
Oligonucleotides Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Oligonucleotides Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Oligonucleotides Market Overview:
Global Oligonucleotides Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Oligonucleotides involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Oligonucleotides Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Oligonucleotides market in 2020.
Global Oligonucleotides Market Segmentation
By Type, Oligonucleotides market has been segmented into:
DNA Oligomers
RNA Oligomers
By Application, Oligonucleotides market has been segmented into:
Genetic Testing
Research
Forensics
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Oligonucleotides market are:
ThermoFisher
Eurofins Genomics
AM Chemicals
TriLink BioTechnologies
Sigma-Aldrich
TAG Copenhagen
Bioneer
Biolegio
IDT
Life biotech
Ella Biotech
SGS DNA
Syntezza Bioscience
Exiqon
Microsynth AG
Bio Basic
BGI
Beijing SBS Genetech
KareBay Biochem Inc.
Eton Bioscience Inc
Biomatik
AltaBioscience
DNA Services Core
AM Biotechnologies LLC
Oligo Factory
Creative Biogene
1. Market Overview of Oligonucleotides
1.1 Oligonucleotides Market Overview
1.1.1 Oligonucleotides Product Scope
1.1.2 Market Status and Outlook
1.2 Oligonucleotides Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Oligonucleotides Historic Market Size by Regions (2015-2020)
1.4 Oligonucleotides Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Oligonucleotides Sales Market by Type (2015-2026)
2.1 Global Oligonucleotides Historic Market Size by Type (2015-2020)
2.2 Global Oligonucleotides Forecasted Market Size by Type (2021-2026)
2.3 DNA Oligomers
2.4 RNA Oligomers
3. Covid-19 Impact Oligonucleotides Sales Market by Application (2015-2026)
3.1 Global Oligonucleotides Historic Market Size by Application (2015-2020)
3.2 Global Oligonucleotides Forecasted Market Size by Application (2021-2026)
3.3 Genetic Testing
3.4 Research
3.5 Forensics
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Oligonucleotides Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Oligonucleotides Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Oligonucleotides Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Oligonucleotides Business
5.1 ThermoFisher
5.1.1 ThermoFisher Company Profile
5.1.2 ThermoFisher Oligonucleotides Product Specification
5.1.3 ThermoFisher Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Eurofins Genomics
5.2.1 Eurofins Genomics Company Profile
5.2.2 Eurofins Genomics Oligonucleotides Product Specification
5.2.3 Eurofins Genomics Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 AM Chemicals
5.3.1 AM Chemicals Company Profile
5.3.2 AM Chemicals Oligonucleotides Product Specification
5.3.3 AM Chemicals Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 TriLink BioTechnologies
5.4.1 TriLink BioTechnologies Company Profile
5.4.2 TriLink BioTechnologies Oligonucleotides Product Specification
5.4.3 TriLink BioTechnologies Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Sigma-Aldrich
5.5.1 Sigma-Aldrich Company Profile
5.5.2 Sigma-Aldrich Oligonucleotides Product Specification
5.5.3 Sigma-Aldrich Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 TAG Copenhagen
5.6.1 TAG Copenhagen Company Profile
5.6.2 TAG Copenhagen Oligonucleotides Product Specification
5.6.3 TAG Copenhagen Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Bioneer
5.7.1 Bioneer Company Profile
5.7.2 Bioneer Oligonucleotides Product Specification
5.7.3 Bioneer Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Biolegio
5.8.1 Biolegio Company Profile
5.8.2 Biolegio Oligonucleotides Product Specification
5.8.3 Biolegio Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 IDT
5.9.1 IDT Company Profile
5.9.2 IDT Oligonucleotides Product Specification
5.9.3 IDT Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Life biotech
5.10.1 Life biotech Company Profile
5.10.2 Life biotech Oligonucleotides Product Specification
5.10.3 Life biotech Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Ella Biotech
5.11.1 Ella Biotech Company Profile
5.11.2 Ella Biotech Oligonucleotides Product Specification
5.11.3 Ella Biotech Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 SGS DNA
5.12.1 SGS DNA Company Profile
5.12.2 SGS DNA Oligonucleotides Product Specification
5.12.3 SGS DNA Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Syntezza Bioscience
5.13.1 Syntezza Bioscience Company Profile
5.13.2 Syntezza Bioscience Oligonucleotides Product Specification
5.13.3 Syntezza Bioscience Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Exiqon
5.14.1 Exiqon Company Profile
5.14.2 Exiqon Oligonucleotides Product Specification
5.14.3 Exiqon Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Microsynth AG
5.15.1 Microsynth AG Company Profile
5.15.2 Microsynth AG Oligonucleotides Product Specification
5.15.3 Microsynth AG Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Bio Basic
5.16.1 Bio Basic Company Profile
5.16.2 Bio Basic Oligonucleotides Product Specification
5.16.3 Bio Basic Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 BGI
5.17.1 BGI Company Profile
5.17.2 BGI Oligonucleotides Product Specification
5.17.3 BGI Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Beijing SBS Genetech
5.18.1 Beijing SBS Genetech Company Profile
5.18.2 Beijing SBS Genetech Oligonucleotides Product Specification
5.18.3 Beijing SBS Genetech Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 KareBay Biochem Inc.
5.19.1 KareBay Biochem Inc. Company Profile
5.19.2 KareBay Biochem Inc. Oligonucleotides Product Specification
5.19.3 KareBay Biochem Inc. Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Eton Bioscience Inc
5.20.1 Eton Bioscience Inc Company Profile
5.20.2 Eton Bioscience Inc Oligonucleotides Product Specification
5.20.3 Eton Bioscience Inc Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Biomatik
5.21.1 Biomatik Company Profile
5.21.2 Biomatik Oligonucleotides Product Specification
5.21.3 Biomatik Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 AltaBioscience
5.22.1 AltaBioscience Company Profile
5.22.2 AltaBioscience Oligonucleotides Product Specification
5.22.3 AltaBioscience Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 DNA Services Core
5.23.1 DNA Services Core Company Profile
5.23.2 DNA Services Core Oligonucleotides Product Specification
5.23.3 DNA Services Core Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.24 AM Biotechnologies LLC
5.24.1 AM Biotechnologies LLC Company Profile
5.24.2 AM Biotechnologies LLC Oligonucleotides Product Specification
5.24.3 AM Biotechnologies LLC Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.25 Oligo Factory
5.25.1 Oligo Factory Company Profile
5.25.2 Oligo Factory Oligonucleotides Product Specification
5.25.3 Oligo Factory Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.26 Creative Biogene
5.26.1 Creative Biogene Company Profile
5.26.2 Creative Biogene Oligonucleotides Product Specification
5.26.3 Creative Biogene Oligonucleotides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Oligonucleotides Market Size (2015-2026)
6.2 North America Oligonucleotides Key Players in North America (2015-2020)
6.3 North America Oligonucleotides Market Size by Type (2015-2020)
6.4 North America Oligonucleotides Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Oligonucleotides Market Size (2015-2026)
7.2 East Asia Oligonucleotides Key Players in North America (2015-2020)
7.3 East Asia Oligonucleotides Market Size by Type (2015-2020)
7.4 East Asia Oligonucleotides Market Size by Application (2015-2020)
8. Europe
8.1 Europe Oligonucleotides Market Size (2015-2026)
8.2 Europe Oligonucleotides Key Players in North America (2015-2020)
8.3 Europe Oligonucleotides Market Size by Type (2015-2020)
8.4 Europe Oligonucleotides Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Oligonucleotides Market Size (2015-2026)
9.2 South Asia Oligonucleotides Key Players in North America (2015-2020)
9.3 South Asia Oligonucleotides Market Size by Type (2015-2020)
9.4 South Asia Oligonucleotides Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Oligonucleotides Market Size (2015-2026)
10.2 Southeast Asia Oligonucleotides Key Players in North America (2015-2020)
10.3 Southeast Asia Oligonucleotides Market Size by Type (2015-2020)
10.4 Southeast Asia Oligonucleotides Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Oligonucleotides Market Size (2015-2026)
11.2 Middle East Oligonucleotides Key Players in North America (2015-2020)
11.3 Middle East Oligonucleotides Market Size by Type (2015-2020)
11.4 Middle East Oligonucleotides Market Size by Application (2015-2020)
12. Africa
12.1 Africa Oligonucleotides Market Size (2015-2026)
12.2 Africa Oligonucleotides Key Players in North America (2015-2020)
12.3 Africa Oligonucleotides Market Size by Type (2015-2020)
12.4 Africa Oligonucleotides Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Oligonucleotides Market Size (2015-2026)
13.2 Oceania Oligonucleotides Key Players in North America (2015-2020)
13.3 Oceania Oligonucleotides Market Size by Type (2015-2020)
13.4 Oceania Oligonucleotides Market Size by Application (2015-2020)
14. South America
14.1 South America Oligonucleotides Market Size (2015-2026)
14.2 South America Oligonucleotides Key Players in North America (2015-2020)
14.3 South America Oligonucleotides Market Size by Type (2015-2020)
14.4 South America Oligonucleotides Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Oligonucleotides Market Size (2015-2026)
15.2 Rest of the World Oligonucleotides Key Players in North America (2015-2020)
15.3 Rest of the World Oligonucleotides Market Size by Type (2015-2020)
15.4 Rest of the World Oligonucleotides Market Size by Application (2015-2020)
16 Oligonucleotides Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Oligonucleotides Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|